Results showed that serum ApoA1 levels in newly diagnosed patients with DLBCL were significantly lower than those in healthy individuals (1.06 ± 0.011 g/L vs. 1.15 ± 0.010 g/L, P < 0.0001; Fig. 2). Here, APOA1 is linked to diffuse large B-cell lymphoma.